Mark Gladwin: Clinical Trials

1 trial sponsored by Mark Gladwin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Mark Gladwin: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Multi-Center Study of Riociguat in Patients With Sickle Cell Diseases
Riociguat, Placebo - Sickle Cell Disease
Phase 2CompletedMark Gladwin1302017-04-112023-07-19

Conditions studied

Anemia, Sickle Cell (1)

Interventions

riociguat (1)

Countries

United States (1)

Results publications

PMID 34889382, PMID 38554715